other payables, mainly the not-yet-due payables for raw materials and packaging ordered from various distributors for use in production of a large volume of products to meet the increased orders from
located in Buriram Province has recorded cost of production in administrative expenses due to plant is undergoing renovation Financial Costs of 16.20 Million Baht as 3.12 Million Baht increased or 23.85
construction in 2019. In Q3/2018 RDF business has sold its product to customer and the company is adjusting the product to suit customer uses. However, the RDF plant is increasing its production and sales slowly
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
subsidiaries as follows: The Company and Subsidiaries Operating Performance of 3rd Quarter Ending September 30th, 2019 Revenues from Sales and Services In Q3 2019, the Company and subsidiaries generated revenues
87.07 million baht. And on process of permission water production and distribution concessions. 2. Waste water treatment system investment project in Myanmar It is an investment form of Build Own and
Company held 99.99% of total shares). Name of the offer persons of the financial assistance : connected persons whose names are as follows; Name-Surname Position in the Company and its subsidiaries
when compared with last year, resulted from the Company sold investment in a subsidiary (S.Thana Media Company Limited) who provides service for rent and advertising production since August 2019. The
period of 2019 To : The President of the Stock Exchange of Thailand The Company would like to provide details of changes in Profit and Loss as shown in the six-month period ending 30 June 2020 reviewed
Corporate Group places importance on internal management as the next priority including production cost management, efficiency improvement on machinery and equipment in order to produce quality goods with